Lipid nanoparticles (LNP) are effective delivery vehicles for messenger RNA (mRNA) and
have shown promise for vaccine applications. Yet there are no published reports detailing …

Detection and characterization of particles in the visible and subvisible size range is critical
in many fields of industrial research. Commercial particle analysis systems have proliferated …

With emerging success in fighting off cancer, chronic infections, and autoimmune diseases,
immunotherapy has become a promising therapeutic approach compared to conventional …

Silicon-based mesoporous nanoparticles have been extensively studied to meet the
challenges in the drug delivery. Functionality of these nanoparticles depends on their …

Vaccines have advanced human health for centuries. To improve upon the efficacy of
subunit vaccines they have been formulated into nano/microparticles for infectious diseases …

The success of clinical and commercial therapeutic proteins is rapidly increasing, but their
potential immunogenicity is an ongoing concern. Most of the studies that have been …

Life-inspired protein supramolecular assemblies have recently attracted considerable
attention for the development of next-generation vaccines to fight against infectious …

The delivery of nucleic acid vaccine to stimulate host immune responses against
Coronavirus disease 2019 shows promise. However, nucleic acid vaccines have …

It is acknowledged that vaccines remain the best hope for eliminating the HIV-1 epidemic.
However, the failure to produce effective vaccine immunogens and the inability of …

In fish, DNA vaccines have been shown to give very high protection in experimental facilities
against a number of viral diseases, particularly diseases caused by rhabdoviruses …